Vivos Therapeutics Ownership | Who Owns Vivos Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Vivos Therapeutics Ownership Summary

Vivos Therapeutics is owned by 5.36% institutional investors, 29.53% insiders, and 65.11% retail investors. Connective capital management is the largest institutional shareholder, holding 2.20% of VVOS shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.03% of its assets in Vivos Therapeutics shares.

VVOS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vivos Therapeutics	5.36%	29.53%	65.11%
Sector	Healthcare Stocks	42.50%	10.81%	46.69%
Industry	Medical Device Stocks	37.66%	10.02%	52.32%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Connective capital management	200.00K	2.20%	$620.00K
Strategic wealth investment group	100.00K	1.10%	$310.00K
Vanguard group	91.46K	1.01%	$283.53K
Geode capital management	53.29K	0.59%	$165.19K
B. riley wealth advisors	43.53K	0.48%	$134.95K
Drw securities	41.47K	0.46%	$128.54K
Commonwealth equity services	41.00K	0.45%	$127.00K
Renaissance	39.28K	0.43%	$121.77K
Blackrock funding, inc. /de	27.82K	0.31%	$86.23K
State street	24.92K	0.27%	$77.26K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Connective capital management	200.00K	0.57%	$620.00K
Strategic wealth investment group	100.00K	0.03%	$310.00K
B. riley wealth advisors	43.53K	0.01%	$134.95K
Drw securities	41.47K	0.00%	$128.54K
Renaissance	39.28K	0.00%	$121.77K
Tower research capital llc (trc)	2.79K	0.00%	$8.66K
Commonwealth equity services	41.00K	0.00%	$127.00K
Kozak & associates	49.00	0.00%	$294.00
Advisor group	6.55K	-	$20.73K
Steward partners investment advisory	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Connective capital management	200.00K	0.57%	200.00K
Strategic wealth investment group	100.00K	0.03%	100.00K
Vanguard group	91.46K	-	48.83K
Drw securities	41.47K	0.00%	41.47K
Renaissance	39.28K	0.00%	39.28K

Top Sellers

Holder	Shares	% Assets	Change
Anson funds management lp	-	-	-242.58K
Ubs group	102.00	-	-142.70K
Envestnet asset management	-	-	-38.87K
B. riley wealth advisors	43.53K	0.01%	-26.00K
Xtx topco	-	-	-20.53K

New Positions

Holder	Shares	% Assets	Change	Value
Connective capital management	200.00K	0.57%	200.00K	$620.00K
Strategic wealth investment group	100.00K	0.03%	100.00K	$310.00K
Drw securities	41.47K	0.00%	41.47K	$128.54K
Renaissance	39.28K	0.00%	39.28K	$121.77K
Blackrock funding, inc. /de	27.82K	-	27.82K	$86.23K

Sold Out

Holder	Change
Steward partners investment advisory	-8.00
Raymond james financial	-74.00
Group one trading	-228.00
Ewa	-10.46K
Xtx topco	-20.53K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	20	11.11%	486,678	21.04%	5	24.47%	10	-	4	300.00%
Jun 30, 2025	17	-15.00%	401,289	-23.45%	4	12.55%	9	-25.00%	1	-
Mar 31, 2025	20	5.26%	524,220	12.11%	6	9.68%	12	100.00%	1	-
Dec 31, 2024	19	-13.64%	467,593	90.82%	7	57.86%	6	-45.45%	1	-50.00%
Sep 30, 2024	22	22.22%	245,048	31.11%	3	11.05%	11	22.22%	2	100.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Institutional Extnd Mkt Idx Tr	60.63K	1.03%	18.00K
Fidelity Extended Market Index	32.44K	0.43%	-267.00
Fidelity Total Market Index	12.14K	0.16%	6.32K
Fidelity Series Total Market Index	9.07K	0.12%	-
NT Ext Equity Mkt Idx Fd - NL	6.80K	0.12%	-
Spartan Extended Market Index Pool E	6.21K	0.11%	242.00
NT Ext Equity Mkt Idx Fd - L	5.63K	0.10%	-
Northern Trust Extended Eq Market Idx	5.63K	0.10%	-
Spartan Extended Market Index Pool F	6.86K	0.09%	267.00
NT Ext Equity Mkt Idx Fd - DC - NL - T2	5.28K	0.09%	-13.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 20, 2023	Huntsman Ronald Kirk	Chief Executive Officer	Buy	$7.42K
Jun 16, 2023	Huntsman Ronald Kirk	Chief Executive Officer	Buy	$5.40K
Jun 16, 2023	Huntsman Ronald Kirk	Chief Executive Officer	Buy	$2.65K
Jun 15, 2023	Huntsman Ronald Kirk	Chief Executive Officer	Buy	$10.50
Jun 14, 2023	Huntsman Ronald Kirk	Chief Executive Officer	Buy	$4.90K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q2	-	-
2023 Q2	5	-
2022 Q4	1	-
2022 Q2	1	-

VVOS Ownership FAQ

Who Owns Vivos Therapeutics?

Vivos Therapeutics shareholders are primarily institutional investors at 5.36%, followed by 29.53% insiders and 65.11% retail investors. The average institutional ownership in Vivos Therapeutics's industry, Medical Device Stocks, is 37.66%, which Vivos Therapeutics falls below.

Who owns the most shares of Vivos Therapeutics?

Vivos Therapeutics’s largest shareholders are Connective capital management (200K shares, 2.20%), Strategic wealth investment group (100K shares, 1.10%), and Vanguard group (91.46K shares, 1.01%). Together, they hold 4.31% of Vivos Therapeutics’s total shares outstanding.

Does Blackrock own Vivos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Vivos Therapeutics.

Who is Vivos Therapeutics’s biggest shareholder by percentage of total assets invested?

Connective capital management is Vivos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.57% of its assets in 200K Vivos Therapeutics shares, valued at 620K$.

Who is the top mutual fund holder of Vivos Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Vivos Therapeutics shares, with 1.03% of its total shares outstanding invested in 60.63K Vivos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools